Interní Med. 2006; 8(9): 380-384

Acute states in phlebology

MUDr. Markéta Kaletová1, MUDr. Dalibor Musil Ph.D2
1 Interní a kardio-angiologická ambulance, Olomouc
2 Cévní ambulance a Ústav patologické fyziologie LF UP a FN Olomouc

Deep vein thrombosis, superficial vein thrombosis and acute leg varices bleeding bring patients a major complications. We summarize information about diagnostic, treatment and prevention those diseases, mainly information about recurrence of deep vein thrombosis, the bleeding risks of anticoagulacion and deciding about duration of anticoagulant therapy. We emphasize the duplex ultrasonography as a fast and easy diagnostic method of venous diseases and importance of this method for early disclosure of superficial vein thrombosis extension to deep vein system. We assume the most importance for acute leg varices bleeding is prevention with surgical removing or sclerotherapy of varicose veins.

Keywords: Key words: deep vein thrombosis, superficial vein thrombosis, acute leg varices bleeding, colour duplex ultrasonography, anticoagulant therapy.

Published: March 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kaletová M, Musil D. Acute states in phlebology. Interní Med. 2006;8(9):380-384.
Download citation

References

  1. Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med 2001; 345: 165-169. Go to original source... Go to PubMed...
  2. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362: 523-526. Go to original source... Go to PubMed...
  3. Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med 2004; 351: 268-277. Go to original source... Go to PubMed...
  4. Decousus H, et al. (Enoxaparin Study Group): A pilot randomized double-blind comparson of a low-molecular-weight heparin, a nonsteroidal anti-infalmmatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med 2003; 163: 1657-1663. Go to original source... Go to PubMed...
  5. Enoxaparin study group: A pilot randomized double-blind comparison of a LMWH, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med 2003; 163: 1657-1663. Go to original source... Go to PubMed...
  6. Ginsberg JS, Wells PS, Kearon C, et al. Senzitivity and specificity of a rapid whole blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med 1998; 129: 1006-1011. Go to original source... Go to PubMed...
  7. Gould MK, Dembitzer AD, Doyle RL, et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute venous thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med 1999; 130: 800-809. Go to original source... Go to PubMed...
  8. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J, August 2000; 21: 1301-1336.
  9. Heijboer H, Buller HR, Lensing AW, Turpie AG, et al. A comparison of rel-time compression ultrasonography with impedance pletysmography for the diagnosis of deep-ven thrombosis in symptomatic outpatients. N Engl Med 1993; 329: 1365-1369. Go to original source... Go to PubMed...
  10. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thrombembolism in the community. Throm. Haemost. 2001; 86: 452-463. Go to original source...
  11. Herman J, a kol. Chirurgie varixů dolních končetin. Praha, Grada Publishing 2003: 200 s.
  12. Hirsh J, Hoak J. Management of dep vein thrombosis and pulmonary embolism: a statement for healthcare professionals. Circulation 1996; 93: 2212. Go to original source... Go to PubMed...
  13. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficasy, ane safety. Chest 2001; 119 (Suppl.): 64S-94S. Go to original source... Go to PubMed...
  14. Hyers TM, Agnelli G, Hull RD, et al. Antitrombotic therapy for venous thrombembolic disease. Chest 2001; 119 (Suppl.): 176S-193S. Go to original source... Go to PubMed...
  15. Hyers TM. Management of Venous Thrombembolism. Arch Intern Med 2003; 163: 759-768. Go to original source... Go to PubMed...
  16. Janssen MCH, Heebels AE, DeMetz M, et al. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis. Thromb Haemost 1997; 77: 262-266. Go to original source... Go to PubMed...
  17. Kakkar VV, et al. Natural histoy or postoperative deep vein thrombosis. Lancet 1969; 2: 230-233. Go to original source... Go to PubMed...
  18. Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive diagnosis of deep venous thrombosis. Ann Intern Med 1998; 128: 663-677. Go to original source... Go to PubMed...
  19. Lee AYY, Levine MN, Baker RI, et al. Low-molecular. weight heparin versus a coumarin for the prevention of recurrent venous thrombembolism in patients with cancer. N Engl J Med 2003; 349: 146-153. Go to original source... Go to PubMed...
  20. Linkins L, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 2003; 139: 893-900. Go to original source... Go to PubMed...
  21. Nordstom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis withis a deifined urban population. J Intern Med 1992; 232: 155-160. Go to original source... Go to PubMed...
  22. Partsch H. Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa 2001; 30: 195-204. Go to original source... Go to PubMed...
  23. Perrier A, Desmarais S, Miron MJ, de Moerloose P, et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190-195. Go to original source... Go to PubMed...
  24. Pinede L, Ninet J, Duhaut P, et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001; 103: 2453-2460. Go to original source... Go to PubMed...
  25. Přerovský I. Arteriální a žilní trombóza. Praha: Galén 2001: 141.
  26. Rieger H, Schoop W. Klinische Angiologie. New York: Springer Verlag, Berlin, Heidelberg 1998: 1420. Go to original source...
  27. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of dep vein thrombosis and pulmonary embolism: a 25. year population-based study. Arch Intern Med 1998; 158: 585-593. Go to original source... Go to PubMed...
  28. Ströbel Ch, Gabler S, Partsch H. Indikationsgerechte Bestrumpfung - Messung der venösen Pumpfunktion. VASA 1989; 18: 35-39. Go to PubMed...
  29. Vojáček J, Malý M, a kol. Arteriální a žilní trombóza v klinické praxi. Grada Publishing 2004; 154.
  30. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335. Go to original source... Go to PubMed...
  31. Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deepvein thrombosis in clinical management. Lancet 1997; 350: 1795-1798. Go to original source... Go to PubMed...
  32. Wells PS, Hirsh J, Anderson DR, Lensing AW, et al. Accuracy of clinical assessment of deepvein thrombosis. Lancet 1995; 345: 1326-1330. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.